Clinical Trial Update: Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing moxifloxacin to amoxicillin-clavulanic acid for acute exacerbations of chronic bronchitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• Augmentin (amoxicillin/clavulanate)
• Avelox (moxifloxacin)

Snippet

Sponsor: Bayer | Conditions: Chronic Bronchitis | Phase 4 | Status: COMPLETED